References
- Babior B. M., Curnutte J. T., Kipnes R. S. Evidence for the participation of superoxide in bacterial killing by xanthine oxidase. J Lab Clin Med 1975; 85: 235
- Bach G. L. Adverse reactions of antirheumatic drugs. Int J Clin Pharmacol 1973; 7: 198
- Balch H. W., Gibson J. M. C., El-Ghobarey A. F., Bain L. S., Lynch M. P. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977; 3: 137
- Biehl G. Klinische Erfahrungen mit Orgotein bei der Behandlung der Arthrosis deformans und extraarticulärer Erkrankungen. Eur J Rheumatol Inflamm 1981; 4: 219
- Carson S., Vogin E. E., Huber W., Schulte T. L. Safety tests of orgotein, an anti-inflammatory protein. Toxicol Appl Pharmacol 1973; 26: 184
- Curnutte J. T., Babior B. M. Biological defense mechanisms: The effect of bacteria and serum on superoxide productions by granulocytes. J Clin Invest 1974; 53: 1662
- Erlich G. E. Osteoarthritis beginning with inflammation. JAMA 1975; 232: 157
- Fridovich I. A free radical pathology: Superoxide radical and superoxide dismutases. Ann Rep Medicinal Chem 1975; 10: 257
- Goebel K. M., Storck U., Neurath F. Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet 1981; 9: 1015
- Greenwald R. A., Moy W. W. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum 1979; 22: 251
- Greenwald R. A., Moy W. W., Lazarus D. Degradation of cartilage proteoglycans and collagen by superoxide radical. Arthritis Rheum 1977; 19: 799
- Hollander J. L., Brown E. M., Jessar R. A., Brown C. Y. Hydrocortisone and Cortisone injected into Arthritic Joints. JAMA 1951; 147: 1629
- Huber W., Schulte T. L., Carson S., Goldhamer R. E., Vogin E. E. Some chemical and pharmacological properties of a novel anti-inflammatory protein. Toxicol Appl Pharmacol 1968; 12: 308
- Lund-Olesen K., Menander K. B. Orgotein: A new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Cum Therap Res 1974; 16: 706
- McCord J. M. Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 1974; 185: 529
- Moskowitz R. W., Goldberg V. M., Berman L. Synovitis as a manifestation of degenerative joint disease: An experimental study. Arthritis Rheum 1976; 19: 813
- Puhl W., Biehl G., Kolbel R., Hofer H. Ergebnis einer multizentrischen Orgotein-Prüfung bei Gonarthrose. Eur J Rheumatol Inflamm 1981; 4: 264
- Rosner I. A., Goldberg S. M., Getzy L., Moskowitz R. W. A trial of intraarticular Orgotein, a superoxide dismutase, in experimentally-induced osteoarthritis. J Rheumatol 1980; 7(1)24
- Salin M. L., McCord J. M. Free radicals and inflammation: Protection of phagocytosing leukocytes by superoxide dismutase. J Clin Invest 1975; 56: 1319
- Walravens M., Dequeker J. Comparison of gold and orgotein treatment in rheumatoid arthritis. Cum Therap Res 1976; 201: 62
- Warren E., Edmondson A. H., Hill H. E., Holmes R. A., Cuthbert L., Warren H. H., Wood W. C. Local administration of Orgotein in horses. Mod Vet Pract 1974; 55: 773
- Weening R. S., Weaver R., Roos D. Quantitative aspects of the productions of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med 1975; 85: 245